Private Institute Briefs

Patent Protection For Worcester Discovery In an effort to speed the development of anti-AIDS drugs—and, perhaps, to profit in the process—the Worcester Foundation for Experimental Biology has patented a class of substances known as anti-sense DNA.” These are pieces of synthetic DNA that have the ability to enter cells and “lock on” to the genes of a virus. The patent, received Feb. 21, is for work conducted by institution scientists Paul C. Zamecnik and John Goodc


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In an effort to speed the development of anti-AIDS drugs—and, perhaps, to profit in the process—the Worcester Foundation for Experimental Biology has patented a class of substances known as anti-sense DNA.” These are pieces of synthetic DNA that have the ability to enter cells and “lock on” to the genes of a virus. The patent, received Feb. 21, is for work conducted by institution scientists Paul C. Zamecnik and John Goodchild showing that anti-sense DNA could inhibit the replication of the AIDS virus in human cells grown in the laboratory. This research was published in the Proceedings of the National Academy of Sciences (volume 83, pages 4143-6, 1986). Although the patented world is still far from producing a cure for AIDS, the institute is actively seeking a collaborator from the pharmaceutical industry for further development of these drugs.

Both the patent and the aggressive search for a collaborator reflect the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development